Diabetes, Vol 49, Issue 7 1209-1218, Copyright © 2000 by American Diabetes Association

ARTICLES

Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients

JE Henriksen, K Levin, P Thye-Ronn, F Alford, O Hother-Nielsen, JJ Holst and H Beck-Nielsen
Diabetes Research Centre, Department of Endocrinology M, Odense University Hospital, Denmark. jeh@dadlnet.dk

With the aim of investigating glucose-mediated glucose disposal (glucose effectiveness [GE]) in 15 (3 female and 12 male subjects) insulin-resistant normoglycemic relatives of patients with type 2 diabetes (DM2), and 15 age-, sex-, and BMI-matched control subjects without a family history of DM2, we performed 2 studies: 1) a 5-h euglycemic near-normoinsulinemic pancreatic clamp with somatostatin (360 microg/h), insulin (0.25 mU x kg(-1) x min(-1)), glucagon (0.5 ng x kg(-1) x min(-1)), growth hormone (6 ng x kg(-1) x min(-1)), and tritiated glucose infusion and indirect calorimetry; and 2) on a separate day, an identical 5-h clamp but at hyperglycemia (approximately 12 mmol/l) over the last 2 h. Fasting plasma insulin (PI) concentrations were elevated in the relatives compared with control subjects (49 +/- 6 vs. 32 +/- 5 pmol/l, P < 0.04), whereas plasma glucose (PG) was not (5.6 +/- 0.1 vs. 5.5 +/-0.1 mmol/l). At the end (i.e., 4.5-5.0 h) of the euglycemic clamp (PG, 6.1 +/- 0.4 vs. 5.6 +/- 0.1 mmol/l; PI, 78 +/- 5 vs. 73 +/-6 pmol/l), peripheral glucose uptake (Rd(euglycemia)) was decreased in the relatives (2.93 +/- 0.08 vs. 3.70 +/-0.23 mg x min(-1) x kg(-1) fat free mass [FFM], P < 0.005), due to a decreased nonoxidative glucose disposal (0.83 +/-0.21 vs. 1.62 +/- 0.19 mg x min(-1) x kg(-1) FFM, P < 0.01), but hepatic glucose production (HGP) was increased (1.97 +/-0.19 vs. 1.50 +/- 0.13 mg x min(-1) x kg(-1) FFM, P < 0.05). At the matched end of the hyperglycemic clamp (PG, 12.7 +/-0.2 vs. 12.6 +/- 0.2 mmol/l; PI, 87 +/- 5 vs. 78 +/- 7 pmol/l), peripheral glucose disposal (Rd(hyperglycemia)) (5.52 +/- 0.22 vs. 5.92 +/- 0.29 mg x min(-1) x kg(-1) FFM, NS), nonoxidative glucose disposal (2.93 +/- 0.18 vs. 2.78 +/- 0.25 mg x min(-1) x kg(-1) FFM, NS), and HGP(hyperglycemia) (1.20 +/- 0.09 vs. 1.37 +/-0.23 mg x min(-1) x kg(-1) FFM, NS) were all identical. When the effectiveness of glucose itself on glucose uptake and production [(Rd(hyperglycemia) - Rd(euglycemia))/deltaPG and (HGP(euglycemia)- HGP(hyperglycemia))/deltaPG] was calculated, the relatives had a 22% increase in peripheral uptake (0.022 +/- 0.002 vs. 0.018 +/- 0.002 mg x min(-1) x kg(-1) FFM per mg/dl), due to a significantly increased nonoxidative glucose metabolism and enhanced suppression of HGP (0.0076 +/- 0.0021 vs. 0.0011 +/- 0.0022 mg x min(-1) x kg(-1) FFM per mg/dl, P < 0.05). In conclusion, in insulin-resistant relatives of DM2 patients, whole-body glucose-mediated glucose disposal is increased by GE enhancement of the muscle nonoxidative glucose pathway and by GE enhancement of the suppression of HGP. These mechanisms may represent a compensatory mechanism to the ongoing insulin resistance of these relatives.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. K. Heilbronn, S. Gregersen, D. Shirkhedkar, D. Hu, and L. V. Campbell Impaired Fat Oxidation After a Single High-Fat Meal in Insulin-Sensitive Nondiabetic Individuals With a Family History of Type 2 Diabetes Diabetes, August 1, 2007; 56(8): 2046 - 2053. [Abstract] [Full Text] [PDF]

				S. G. Moesgaard, C. L. Brand, J. Sturis, B. Ahren, M. Wilken, J. Fleckner, R. D. Carr, O. Svendsen, A. J. Hansen, and D. X. Gram Sensory nerve inactivation by resiniferatoxin improves insulin sensitivity in male obese Zucker rats Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1137 - E1145. [Abstract] [Full Text] [PDF]

				M. F. Nielsen, A. Caumo, N. K. Aagaard, V. Chandramouli, W. C. Schumann, B. R. Landau, O. Schmitz, and H. Vilstrup Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1135 - G1143. [Abstract] [Full Text] [PDF]

				C. S. Carter, M. Cesari, W. T. Ambrosius, N. Hu, D. Diz, S. Oden, W. E. Sonntag, and M. Pahor Angiotensin-Converting Enzyme Inhibition, Body Composition, and Physical Performance in Aged Rats J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2004; 59(5): B416 - B423. [Abstract] [Full Text] [PDF]

				H. Oberkofler, V. Linnemayr, R. Weitgasser, K. Klein, M. Xie, B. Iglseder, F. Krempler, B. Paulweber, and W. Patsch Complex Haplotypes of the PGC-1{alpha} Gene Are Associated With Carbohydrate Metabolism and Type 2 Diabetes Diabetes, May 1, 2004; 53(5): 1385 - 1393. [Abstract] [Full Text] [PDF]

				R. C. Bonadonna, M. Stumvoll, A. Fritsche, M. Muggeo, H. Haring, E. Bonora, and T. W. van Haeften Altered Homeostatic Adaptation of First- and Second-Phase {beta}-Cell Secretion in the Offspring of Patients With Type 2 Diabetes: Studies With a Minimal Model to Assess {beta}-Cell Function Diabetes, February 1, 2003; 52(2): 470 - 480. [Abstract] [Full Text] [PDF]

				C. B. Jensen, H. Storgaard, F. Dela, J. J. Holst, S. Madsbad, and A. A. Vaag Early Differential Defects of Insulin Secretion and Action in 19-Year-Old Caucasian Men Who Had Low Birth Weight Diabetes, April 1, 2002; 51(4): 1271 - 1280. [Abstract] [Full Text] [PDF]

				C. Schwanstecher, U. Meyer, and M. Schwanstecher KIR6.2 Polymorphism Predisposes to Type 2 Diabetes by Inducing Overactivity of Pancreatic {beta}-Cell ATP-Sensitive K+ Channels Diabetes, March 1, 2002; 51(3): 875 - 879. [Abstract] [Full Text] [PDF]

				S. R. Commerford, M. E. Bizeau, H. McRae, A. Jampolis, J. S. Thresher, and M. J. Pagliassotti Hyperglycemia compensates for diet-induced insulin resistance in liver and skeletal muscle of rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1380 - R1389. [Abstract] [Full Text] [PDF]